Chemical, Structural, Clinical and Biological details of Antiviral agents ID: DrugRepV_2136



Chemical Information
Antiviral agent IDDrugRepV_2136
Antiviral agent name7-deaza-2-C-methyl-D-adenosine
IUPAC Name(2R,3R,4R,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyloxolane-3,4-diol PubChem
SMILES (canonical)CC1(C(C(OC1N2C=CC3=C2N=CN=C3N)CO)O)O PubChem
SMILES (isomeric)C[C@]1([C@@H]([C@H](O[C@H]1N2C=CC3=C2N=CN=C3N)CO)O)O PubChem
Molecular FormulaC12H16N4O4 PubChem
Molecular Weight (g/mol)280.284 PubChem
InChlInChI=1S/C12H16N4O4/c1-12(19)8(18)7(4-17)20-11(12)16-3-2-6-9(13)14-5-15-10(6)16/h2-3,5,7-8,11,17-19H,4H2,1H3,(H2,13,14,15)/t7-,8-,11-,12-/m1/s1 PubChem
Structural Information
  
Clinical Information
Biological Information
Primary Indication (Disease Category) Infectious Disease
Primary Indication (Disease)Viral infection
Secondary Indication Zika virus (ZIKV) NA MR766World Health OrganisationCDC
Secondary Indication (Approaches)Experimental
Secondary Indication (Methods)in-vitro
Secondary Indication (Model system) [cell lines/ animal models]Vero
Secondary Indication (Mode of viral infection)Adsorption
Secondary Indication (Mode of drug delivery) Culture
Secondary Indication (Drug concentration)1.3 μM
Secondary Indication (Cell based assay)Plaque assay
Secondary Indication (Change)Decrease
Secondary Indication (Type of Inhibition) EC50 [ 50 % ]
ReferenceZmurko J, Marques RE, Schols D, Verbeken E, Kaptein SJ, Neyts J..The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika V.PLoS Negl Trop Dis. 2016 May 10;10(5):e0004695. doi: 10.1371/journal.pntd.0004695. eCollection 2016 PMID:27163257 PubMed
CommentAG129 mice can generate an antibody response, and have been used in dengue vaccine studies, the model can also be used to assess the efficacy of ZIKV vaccines.